Clinical UpdatesschizophreniaGLP-1 receptor agonists
GLP-1 Receptor Agonists and Psychiatric Acute-Care Outcomes in Schizophrenia with Type 2 Diabetes: Insights from Real-World EHR Data
By MedXY|Oct 19, 2026
This review synthesizes evidence on GLP-1 receptor agonist initiation impacting psychiatric hospitalisation and emergency visits in adults with schizophrenia and type 2 diabetes, highlighting metabolic and psychiatric interplay and therapeu